Loading
Latest filing published 17 Jul 2026 for Catalyst Pharmaceuticals, INC., €64k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of William T. Andrews across 2 companies, led by Catalyst Pharmaceuticals, Inc. and Flexion Therapeutics Inc. Between 2 August 2021 and 15 July 2026, the trades on record add up to 5 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 17 July 2026: a transaction of €64k, in Catalyst Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations